C-Rad AB (publ) (STO:CRAD.B)
Sweden · Delayed Price · Currency is SEK 32.10
+0.10 (0.31%)
At close: Jan 20, 2026
C-Rad AB Revenue
C-Rad AB had revenue of 112.20M SEK in the quarter ending September 30, 2025, with 12.09% growth. This brings the company's revenue in the last twelve months to 457.60M, down -5.83% year-over-year. In the year 2024, C-Rad AB had annual revenue of 469.00M with 10.45% growth.
Revenue (ttm)
457.60M
Revenue Growth
-5.83%
P/S Ratio
2.36
Revenue / Employee
4.28M
Employees
99
Market Cap
1.08B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 469.00M | 44.39M | 10.45% |
| Dec 31, 2023 | 424.62M | 123.29M | 40.92% |
| Dec 31, 2022 | 301.33M | 40.17M | 15.38% |
| Dec 31, 2021 | 261.15M | 39.52M | 17.83% |
| Dec 31, 2020 | 221.63M | 16.23M | 7.90% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BICO Group AB | 1.78B |
| CellaVision AB | 748.45M |
| Paxman AB | 305.02M |
| Mentice AB | 275.97M |
| Bactiguard Holding AB | 217.83M |
| Sedana Medical AB | 197.61M |
| OssDsign AB | 176.48M |
| Senzime AB | 89.71M |
C-Rad AB News
- 3 months ago - C-Rad AB (FRA:24C) Q3 2025 Earnings Call Highlights: Strong Service Growth Amidst Regional ... - GuruFocus